The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods

Do Clinicians Overestimate the Severity of Intracerebral Hemorrhage?

(2019) Elliot J. Tilling et al.   STROKE

Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke

(2018) Bijoy K. Menon et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study)

(2018) Ketevan Berekashvili et al.   Journal of Stroke & Cerebrovascular Diseases

Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)

(2017) Andrew D. Barreto et al.   STROKE

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials

(2016) Mayank Goyal et al.   LANCET

Endovascular Thrombectomy for Acute Ischemic Stroke

(2015) Jetan H. Badhiwala et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke

(2015) Tudor G. Jovin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke

(2015) Jeffrey L. Saver et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

(2015) Mayank Goyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection

(2015) Bruce C.V. Campbell et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

(2015) Olvert A. Berkhemer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale

(2015) Napasri Chaisinanunkul et al.   STROKE

Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial

(2015) Opeolu Adeoye et al.   STROKE

Impact of Time to Treatment on Tissue-Type Plasminogen Activator–Induced Recanalization in Acute Ischemic Stroke

(2014) Marian Muchada et al.   STROKE

Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial

(2013) Arthur M. Pancioli et al.   STROKE

The Argatroban and Tissue-Type Plasminogen Activator Stroke Study

(2012) Andrew D. Barreto et al.   STROKE

Timing of Recanalization After Intravenous Thrombolysis and Functional Outcomes After Acute Ischemic Stroke

(2012) Leonard L. L. Yeo et al.   JAMA Neurology

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Effects of 0.6 mg/kg Intravenous Alteplase on Vascular and Clinical Outcomes in Middle Cerebral Artery Occlusion

(2010) Etsuro Mori et al.   STROKE

Pharmacology of argatroban

(2010) Walter P Jeske et al.   Expert Review of Hematology

Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome

(2009) Oliver Rivero-Arias et al.   MEDICAL DECISION MAKING

Quantifying the Value of Stroke Disability Outcomes

(2009) Keun-Sik Hong et al.   STROKE

Treatment effects for which shift or binary analyses are advantageous in acute stroke trials

(2008) J. L. Saver et al.   NEUROLOGY

Mechanisms of Thrombus Formation

(2008) Bruce Furie et al.   NEW ENGLAND JOURNAL OF MEDICINE

The C ombined Approach to L ysis Utilizing E ptifibatide a nd r t-PA in Acute Ischemic Stroke

(2008) Arthur M. Pancioli et al.   STROKE